Infectious Disease & Vaccines
Part of Biotech - Drug Development
 MRK | Merck & Co., Inc. | $293.2b | $128.22 | +1.7% | 9.8M |
 GILD | Gilead Sciences Inc | $166.9b | $127.40 | +2.8% | 7.2M |
 PFE | Pfizer Inc. | $149.2b | $24.27 | +2.5% | 36.0M |
 MRNA | Moderna, Inc. Common Stock | $18.7b | $67.14 | +12.6% | 12.8M |
 SMMT | Summit Therapeutics Inc. Common Stock | $13.6b | $14.11 | -1.1% | 2.6M |
 PCVX | Vaxcyte, Inc. Common Stock | $7.4b | $51.20 | +5.2% | 2.6M |
 BCRX | BioCryst Pharmaceuticals Inc | $2.3b | $9.99 | +0.6% | 5.6M |
 NVAX | Novavax Inc | $1.8b | $8.85 | +3.7% | 3.6M |
 VIR | Vir Biotechnology, Inc. Common Stock | $1.6b | $10.18 | +2.0% | 2.0M |
 ABUS | Arbutus Biopharma Corporation Common Stock | $0.9b | $4.56 | +3.6% | 2.9M |
 CRMD | CorMedix Inc. | $0.7b | $7.81 | +2.2% | 1.8M |
 ASMB | Assembly Biosciences, Inc | $0.5b | $26.15 | +10.3% | 425.6K |
 EBS | Emergent Biosolutions, Inc. | $470.6m | $8.44 | +6.9% | 919.0K |
 ENTA | Enanta Pharmaceuticals, Inc | $382.7m | $14.67 | +3.9% | 201.7K |
 AVIR | Atea Pharmaceuticals, Inc. Common Stock | $373.7m | $4.37 | +3.2% | 241.3K |
 IVVD | Invivyd, Inc. Common Stock | $335.9m | $0.90 | +1.7% | 2.1M |
 SIGA | SIGA Technologies Inc. | $335.7m | $3.92 | -1.0% | 547.2K |
 ARMP | Armata Pharmaceuticals, Inc. Common Stock | $299.9m | $7.44 | +13.8% | 464.5K |
 ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | $225.1m | $7.03 | +0.7% | 398.0K |
 TNXP | Tonix Pharmaceuticals Holding Corp. | $196.6m | $12.65 | +10.7% | 954.3K |
 SPRO | Spero Therapeutics, Inc. Common Stock | $163.9m | $2.29 | +10.6% | 1.9M |
 ANTX | AN2 Therapeutics, Inc. Common Stock | $155.9m | $5.14 | -0.1% | 491.0K |
 INO | Inovio Pharmaceuticals, Inc. | $107.8m | $1.10 | +0.9% | 1.1M |
 XBIT | XBiotech Inc | $73.8m | $2.32 | -0.4% | 54.8K |
 MCRB | Seres Therapeutics, Inc. | $70.9m | $7.04 | +3.6% | 285.7K |
 ZTEK | Zentek Ltd. Common Stock | $63.8m | $0.44 | +25.8% | 2.0M |
 IBO | Impact BioMedical, Inc. | $56.1m | $0.49 | -1.1% | 26.9K |
 ATOS | Atossa Therapeutics, Inc. Common Stock | $45.0m | $1.90 | +6.8% | 342.8K |
 NNVC | NanoViricides Inc. | $40.5m | $1.34 | +4.2% | 180.6K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $35.3m | $5.58 | 0.0% | 35.7K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $33.1m | $7.42 | -4.5% | 12.5K |
 PLRZ | Polyrizon Ltd. Ordinary Shares | $32.1m | $11.54 | 0.0% | 4.0K |
 CODX | Co-Diagnostics, Inc. Common Stock | $31.4m | $3.08 | +0.3% | 96.8K |
 TRAW | Traws Pharma, Inc. Common Stock | $22.1m | $0.83 | +0.9% | 121.0K |
 COCP | Cocrystal Pharma, Inc. Common Stock | $15.4m | $1.02 | +0.5% | 57.3K |
 MBRX | Moleculin Biotech, Inc. | $14.9m | $3.36 | +12.9% | 1.3M |
 SNGX | Soligenix, Inc. Common Stock | $13.5m | $0.40 | +4.2% | 588.6K |
 PHGE | BiomX Inc. | $12.8m | $0.42 | +6.3% | 316.9K |
 GOVX | GeoVax Labs, Inc. New | $10.7m | $1.29 | +0.8% | 203.6K |
 IMNN | Imunon, Inc. Common Stock | $9.2m | $1.91 | +1.7% | 71.8K |
 ACXP | Acurx Pharmaceuticals, Inc. Common Stock | $8.5m | $1.51 | +8.5% | 43.5K |
 APM | Aptorum Group Limited Class A Ordinary Shares | $8.4m | $0.78 | 0.0% | 31.8K |
 XBIO | Xenetic Biosciences, Inc. | $7.2m | $2.98 | +6.7% | 8.9K |
 SCYX | SCYNEXIS, Inc. | $7.0m | $3.88 | -2.2% | 48.3K |
 AIM | AIM ImmunoTech Inc. | $5.9m | $0.31 | -12.6% | 2.0M |
 SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | $4.0m | $1.62 | -1.8% | 30.9K |
 ITRM | Iterum Therapeutics plc Ordinary Share | $3.8m | $0.03 | +5.0% | 43.6M |
 AEMD | AETHLON MEDICAL INC | $3.5m | $0.93 | +3.1% | 264.6K |
 VRAX | Virax Biolabs Group Limited Ordinary Shares | $1.4m | $3.46 | -7.6% | 629.9K |
 SBFM | Sunshine Biopharma Inc. | $410.8k | $2.10 | +1.4% | 59.0K |